Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

INTRODUCTION: The soluble urokinase-type plasminogen activator receptor (suPAR) has recently been associated with a decline in kidney function and incidence of chronic kidney disease in patients with cardiovascular disease undergoing cardiac catheterization, yet little is known whether suPAR is asso...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Schulz, Christina-Alexandra, Persson, Margaretha, Christensson, Anders, Hindy, George, Almgren, Peter, Nilsson, Peter M., Melander, Olle, Engström, Gunnar, Orho-Melander, Marju
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362148/
https://ncbi.nlm.nih.gov/pubmed/28367534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2016.11.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars